Palacios-Mancilla SM, Rubio-Lezama MÁ, Torre-López MJ, Arrevillaga-López AE

Language: Spanish
References: 19
Page: 285-288
PDF size: 76.47 Kb.

ABSTRACT

Objective: to describe cardiovascular risk factors in pediatric patients of the General Hospital Zone 58 and its relationship with metabolic abnormalities.
Methods: we studied a population of 30 healthy; children randomized. We measured weight, height, body mass index, blood pressure, waist circumference, determination of blood glucose, total cholesterol, HDL, LDL, triglycerides and uric acid. We applied a structured questionnaire about: how many hours a day the child watch television, hours of sleeping, birth weight, consumption of junk food, plus additional questions to investigate family history of cardiovascular disease.
Results: the group consisted of 17 girls (56 %) and 13 boys (44 %), average age: 9.7 years. Patients who had at least one abnormal laboratory result were 27 (90 %). Cardiovascular risk factors showed an arithmetic mean birth weight 3175 g, 3.6 h hours of watching TV, sleep diary 8.9, junk food every day 2.9. 15 patients had normal BMI, 5 more than the 95 centile and 7 below the 10 centile.
Conclusions: the main factor that determined metabolic disorders was family history of cardiovascular disease or lipid disorders.

REFERENCES

1. Aguilar A, Rojas R, Gómez-Pérez FJ, Franco A, Olaiz G, Rull JA, Sepúlveda J. El síndrome metabólico: un concepto en evolución. Gac Med Mex 2004;140(Supl 2):S41-S48.

2. Aradillas-García C, de la Cruz-Mendoza E, Torres-Ruvalcaba B, Montreal-Escalante E, Torres-Rodríguez L, Goldaracena- Azuara M. El impacto de la televisión sobre la prevalencia del síndrome metabólico en población infantil de San Luis Potosí. Bioquimia 2008;33(1):10-18. Disponible en http://www.medigraphic.com/pdfs/bioquimia/bq-2008/bq081c.pdf

3. Sinaiko AR, Jacobs DR Jr, Steinberger J, Moran A, Luepker R, Rocchini AP, et al. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr 2001;139(5):700-707.

4. Pankow JS, Jacobs DR Jr, Steinberger J, Moran A, Sinaiko AR. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care 2004;27(3):775-780.

5. Heller-Rouassant S. Dislipidemia en niños y adolescentes: diagnóstico y prevención. Bol Med Hosp Infant Mex 2006; 63:158-161. Disponible en http://new.medigraphic.com/cgibin/contenido.cgi?IDREVISTA=100&IDPUBLICACION=1021

6. Salazar-Vázquez B, Rodríguez-Morán M,Guerrero-Romero F. Factores bioquímicos asociados a riesgo cardiovascular en niños y adolescentes. Rev Med Inst Mex Seguro Soc 2005;43(4):299-303. Disponible en http://201.144.108.128/revista_medica/index.php?option=com_multicategories&view=article&id=1309:factores-bioquimicos-asociadosa-riesgo-cardiovascular-en-ninos-y-adolescentes-&Itemid=646

7. Aguilar-Arenas G, Canela-Gutiérrez J. Hipercolesterolemia en niños ¿un problema real? Rev Mex Patol Clin 2008;55 (2);59-64.

8. García-García E, De la Llata-Romero M, Kaufer-Horwitz M, Tusié-Luna MT, Calzada-León R, Vázquez-Velázquez V, et al. La obesidad y el síndrome metabólico como problema de salud pública: una reflexión. Salud Publica Mex 2008; 50(6):530-547. Disponible en http://www.artemisaenlinea.org.mx/acervo/pdf/revista_investigacion_clinica/La%20obesidad%20y%20el% 20sindrome.pdf

9. Lara A, Rosas M, Pastelín G, Aguilar C, Attié F, Velásquez MO. Hipercolesterolemia e hipertensión arterial en México: Consolidación urbana actual con obesidad, diabetes y tabaquismo. Arch Cardiol Mex 2004;74:231-245. Disponible en http://www.medigraphic.com/pdfs/archi/ac-2004/ac043k.pdf

10. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents. Lancet 2007;369(9579):2059-2061.

11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-2497.

12. Rosas-Peralta M. Definición de síndrome metabólico: la torre de Babel. Arch Cardiol Mex 2005;75:230-233. Disponible en http://www.scielo.org.mx/pdf/acm/v75n2/v75n2a17.pdf

13. Secretaría de Salud. Norma Oficial Mexicana NOM-043-SSA2-2005, Servicios básicos de salud. Promoción y educación para la salud en materia alimentaria. Criterios para brindar orientación. México: Diario Oficial de la Federación del 26 de enero de 2006.

14. Phillips D, Barker D, Fall C, Seckl JR, Whorwood CB, Wood PJ, et al. Elevated plasma cortisol concentrations: Disponible en between low birth weight and the insulin resistance syndrome? J Clin Endocrinol Metab 1998;83(3):757-760.

15. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva; WHO: 1998.

16. Velázquez O, Rosas M, Lara A, Pastelín HG, Sánchez CC, Grupo ENSA-2000, et al. Prevalencia en interrelación de las enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México. Arch Cardiol Mex 2003;73:62-77.

17. López AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367(9524):1747-1757.

18. Álvarez HA, Cabrera HA, Puga GR, Omechevarría PE. Estudio del metabolismo lipídico en una población de niños supuestamente sanos. Rev Cubana Med Gen Integr 1995; 11(3). Disponible en http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21251995000300006

19. Treviño RP, Yin Z, Hernández A, Hale DE, García OA, Mobley C. Impact of the comfort school based diabetes mellitus prevention program on fasting capillary glucose levels. Arch Pediatr Adolesc Med 2004;158(9):911-917. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364479/?tool=pubmed